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Variation in the gut microbiome has been linked to colorectal cancer (CRC), as well as to                               
host genetics. However, we do not know whether genetic mutations in CRC tumors interact with                             
the structure and composition of the microbial communities surrounding the tumors, and if so,                           
whether changes in the microbiome can be used as a predictor for tumor mutational status. Here,                               
we characterized the association between CRC tumor mutational landscape and its proximal                       
microbial communities by performing whole­exome sequencing and microbiome profiling in                   
tumors and normal colorectal tissue samples from the same patient. We find a significant                           
association between loss­of­function mutations in relevant tumor genes and pathways and shifts                       
in the abundances of specific sets of bacterial taxa. In addition, by constructing a risk index                               
classifier from these sets of microbes, we accurately predict the existence of loss­of­function                         
mutations in cancer­related genes and pathways, including MAPK and Wnt signaling, solely                       
based on the composition of the microbiota. These results can serve as a starting point for                               
understanding the interactions between host genetic alterations and proximal microbial                   
communities in CRC, as well as for the development of individualized microbiota­targeted                       
therapies. 
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 Introduction 
The human gut is host to approximately a thousand different microbial species consisting                         
of both commensal and potentially pathogenic members 1 . In the context of colorectal cancer                         
(CRC), it is clear that bacteria in the microbiome play a role in human cell signaling 2–11 ; for                                 
example, in the case of CRC tumors that are host to the bacterium  Fusobacterium nucleatum , the                               
microbial genome encodes a virulence factor,  FadA , that can activate the β­catenin pathway 12 . In                           
addition, several attempts have been made to predict CRC status using the microbiome as a                             
biomarker 13–16 . It has been shown that focusing on a single bacterial species,  F. nucleatum , it is                               
possible to predict some clinically relevant features of the tumor present 17 . However, as only a                             
minority of CRCs are host to  F. nucleatum , this is a somewhat limited application 18 . Other                             
specific microbes have been linked to CRC, including  Escherichia coli  harboring polyketide                       
synthase (pks) islands, as reported by one group 19,20 and enterotoxigenic  Bacteroides Fragilis                       
(ETBF) by another 21–23 . The mechanism of action of these associations is still under investigation                           
with  F.  nucleatum  being  the  most  clearly  developed 12 .  
In healthy individuals, host genetic variation can affect the composition of the                       
microbiome 24–29 , and the associated human genetic variants are enriched in cancer­related genes                       
and pathways 25 . However, it is still unknown whether somatic mutations in host cells can affect                             
the composition of the microbiome that directly interacts with host tissues. Here, we aim to find                               
(i) whether variation in somatic mutational profiles in CRC tumors is associated with variation in                             
the microbiome; (ii) which host genes and bacterial taxa drive the association; (iii) how these                             
patterns can shed light on the molecular mechanisms controlling host­microbiome interaction in                       





We performed whole­exome sequencing on a set of 88 samples, comprised of 44 pairs of                             
tumor (adenocarcinomas) and normal colon tissue sample from the same patient, with previously                         
characterized tissue­associated microbiomes 2 . The mutations in each of the tumors’                   
protein­coding regions were identified relative to the patient­matched normal sample and                     
annotated as either synonymous, non­synonymous, or loss­of­function (LoF) mutations                 
(Supplementary Figs. 1­2, and Supplementary Tables 1­2). The mutations were collapsed by                       
gene as well as by pathways using both Kyoto Encyclopedia of Genes and Genomes (KEGG)                             
and  pathway  interaction  database  (PID)  annotations 30–33 .  
We first investigated the relationship between microbial communities and tumor stage                     
(Fig. 1). We hypothesize that the structure and composition of the associated microbiome can be                             
affected by relevant physiological and anatomical differences between the tumors at different                       
stages that would provide different microenvironmental niches for microbes. We identified the                       
changes in the microbial communities surrounding each tumor as a function of stage by grouping                             
the tumors into low stage (stages 1­2) and high stage (stages 3­4) classes and applied linear                               
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 discriminant analysis (LDA) effect size (LEfSe) to the raw operational taxonomic unit (OTU)                         
tables corresponding to these tumors (Supplementary Tables 3­4) 34 . The set of taxon abundances                         
was transformed to generate a single value representing a risk index classifier for membership in                             
the low­stage or high­stage group (Fig. 1a; see Methods). To ascertain the error associated with                             
these risk indices, a leave­one­out (LOO) cross­validation approach was applied. We also used                         
the LOO results to generate receiver operating characteristic (ROC) curves and to calculate the                           
area under the curve (AUC; see Fig. 1b). In addition, we performed a permutation test to assess                                 
the method’s robustness (Supplementary Table 4). Using this approach, we demonstrate that the                         
changes in abundances of 31 microbial taxa can be used to generate a classifier that distinguishes                               
between low­stage and high­stage tumors at a fixed specificity of 80% and an accuracy of 77.5%                               
(P = 0.02 by Mann­Whitney U test, and P = 0.007 by a permutation test; Supplementary Table                                 
4).The resulting changes seen in our analysis of the microbial communities that vary by tumor                             
stage were similar to those found in previous studies, including one using a Chinese patient                             
cohort 4,35 . In both cases, there were significant changes among several taxa within the phylum                           




Next, we attempted to use a similar approach to classify tumors based on mutational                           
profiles. We initially focused on individual genes that harbor loss­of­function (LoF) mutations,                       
as those, we predicted, would be the most likely to have a physiologically relevant interaction                             
with the surrounding microbiome. A prevalence filter was applied to include only those                         
mutations that were present in at least 10 or more patients at the gene level. The raw OTU table                                     
was collapsed to the level of genus for the analysis. A visualization of the correlations between                               
gene­level mutational status and the associated microbial abundances revealed differing patterns                     
of abundances that suggests an interaction between the 11 most prevalent LoF tumor mutations                           
and the microbiome (Supplementary Fig. 3). We hypothesized that the presence of                       
mutation­specific patterns of microbial abundances could be statistically described by prediction                     
of tumor LoF mutations in individual genes using the microbiome. For each of eleven genes that                               
passed prevalence filtering cutoff, we identified the associated microbial taxa (Fig. 2a and                         
Supplementary Tables 5­6), generated risk indices for each patient (Fig. 2b­c), and plotted the                           
mean differences in abundances for a subset of microbial taxa interacting with each mutation                           
(Fig. 2d). We found that we are able to use microbiome composition profiles to predict the                               
existence of tumor LoF mutations in the human genes  APC ,  ANKRD36C ,  CTBP2 ,  KMT2C , and                           
ZNF717  (Q­value = 0.0011, 0.0011, 0.019, 0.019, and 0.055, respectively, by permutation test                         
after False Discovery Rate (FDR) correction for multiple tests with a Q value threshold of 0.10;                               
Fig. 2). The risk indices for each mutation were generated using sets of microbial taxa that                               
ranges from 22 ( ZNF717 ) to 53 ( ANKRD36C ) taxa (Supplementary Table 5). The taxa that                           
showed the most dramatic differences in abundance when comparing tumors with and without                         
mutations are shown in Fig. 2d. For example, the abundance of  Christensenellaceae is relatively                           
lower  in  tumors  with  APC  mutations,  but  relatively  higher  in  tumors  with  ZNF717  mutations.  
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 Next, we applied our interaction prediction approach, as described above, to the                       
pathway­level mutational data (see Methods). Following visualization of the pathway level                     
abundances (Supplementary Figs. 4­5) and applying the model, we found that each of the 21                             
KEGG pathways passing prevalence filter were able to be significantly predicted with a fixed                           
specificity of 80% and an accuracy up to 86% (Q­values < 0.02 by permutation test after FDR                                 
correction; Fig. 3a­d, Supplementary Figs. 6­7, and Supplementary Table 7), as were 15 of the 19                               
tested PID pathways (Q­values < 0.04 by permutation test after FDR correction) (Fig. 3e­h, and                             
Supplementary Figs. 8­9, and Supplementary Table 7). The taxon abundances that were                       
specifically associated (direct or inverse correlations) with each of the LoF mutations in the                           
genes and pathways can be found in Supplementary Tables 8­11 and Supplementary Fig. 10. In                             
general, the number of taxa within each of the sets used to generate the risk indices was lower                                   
than that used for the gene­level analyses (average of 37 taxa per gene­associated set compared                             
to 7 taxa per set associated with mutations in KEGG or PID pathways). When comparing results                               
using the gene­level interactions and the pathway level interactions, for instance looking at                         
mutations in  APC (Fig. 2) and comparing them to mutations in the KEGG­defined Wnt signaling                             
pathway and the PID­defined Canonical Wnt signaling pathway (Fig. 3), the interactions at the                           
pathway level are more statistically significant (AUC for  APC  = 0.81, KEGG = 0.88, PID =                               




Lastly, we assessed the correlations between taxa among tumors with and without LoF                         
mutations (Fig. 4; see methods). We found striking differences in structure of the network                           
comparing tumors with and without a Lof mutation in  APC the correlations between taxa (Fig.                             
4a). For example, in tumors with mutations in  APC , the abundance of  Christensenellaceae is                           
positively correlated with  Rhodocyclaceae and negatively correlated with  Pedobacter . In tumors                     
lacking LoF mutations in  APC , these correlations are lost and  Christensenellaceae is instead                         
negatively correlated with  Saprospiraceae and  Gemm 1 . We also assessed the network of                         
correlations across tumors with mutations in PID pathways (Fig. 4B). This analysis highlighted                         
that some pathway­level mutations show a shared set of correlations between taxa, while others                           
appear independent. Several of the taxa that can be used to predict LoF mutations in p75(NTR)                               




The link between colorectal cancer and the gut microbiome has been highlighted by a                           
large number of recent studies  2–18 , with several hypotheses as to the causal role of microbes in                                 
the disease  9,12,36,37 . Since cancer is a genetic disease caused by mutations in host DNA, it is of                                   
interest to study the microbiome in the context of tumor mutational profiles, especially given                           
recent studies showing an impact of host genetics on the microbiome 24–29 . Here, we jointly                           
4 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/090795doi: bioRxiv preprint first posted online Dec. 1, 2016; 
 analyzed tumor coding mutational profile and the taxonomic composition of the proximal                       
microbiome. We found that the composition of the proximal microbiome is correlated with                         
mutations in tumor DNA, and that this correlation can be used to predict mutated genes and                               
pathways  solely  based  on  the  microbiome. 
We performed quality control of the data and stringent filtering at every step ( e.g. ,                           
requiring 30x coverage at a site in both the tumor and matched normal sample to call a mutation;                                   
see methods). While these requirements are likely to increase the frequency of false negatives                           
(true mutations that simply do not meet our criteria), this rigorous strategy is appropriate as a                               
means of increasing the biological relevance of our findings. Of note, when comparing the                           
common LoF mutations found in our dataset to those found in colorectal tumors sampled as part                               
of The Cancer Genome Atlas (TCGA) project, we find several commonalities, including a high                           
frequency of LoF mutations in  APC,  as well as numerous missense mutations in  KRAS ,  NRAS,                             
and  TP53 , as expected (Supplementary Table 1) 38 . In general, the numbers of mutations across                           
our sample set were also in line with those identified at part of the TCGA (Supplementary Table                                 
2) 38 
The association of microbial taxa with tumor stage (Fig. 1) mirrors recent results,                         
including a study of a Chinese population 4,35 . This concordance is relevant as it indicates that the                               
microbial communities appear to be consistent even when comparing geographically distinct                     
patient cohorts 39,40 . One of the predictive taxa,  Porphyromonadaceae ,  has been shown to be                         
altered in mouse models of CRC in other studies as well 7,14 . A study on the link between                                 
dysbiosis and colitis­induced colorectal cancer also showed similar results 41 . For instance, the                       
bacterial genus  Paludibacter was found to be associated with risk of developing tumors in a                             
mouse model 41 . We find that  Paludibacter is significantly associated with low­stage tumors,                       
again, supporting the hypothesis that these bacteria as associated with cancer risk and may be                             
contributing to early stage inflammation 41 . Conversely, we found that the genus  Coprococcus is                         
associated with high­stage tumors and not low stage tumors. Members of this genus are known to                               
generate butyrate and propionate, which in this context can act as antiinflammatory short chain                           
fatty acids 42 . Although our results are correlational and cannot point to causal effects, these                           
findings suggest that driving inflammation may play a role in early stage cancer, while                           
generating nutrients at the cost of suppressing inflammation may be more beneficial to the tumor                             
in  later  stages. 
Gene­level mutation data, visualized in Supplementary Fig. 3, show intriguing patterns of                       
microbial abundances that are associated with the tumors harboring different mutations. For                       
instance, as reflected in the differing patterns within each gene (rows) in the heatmap,                           
Aerococcus and  Dorea are both show higher scaled abundances within tumors harboring                       
mutations in  ZNF717 ,  CTBP2 , and  APC , relative to tumors with LoF mutations in  ANKRD36C                           
and  KMT2C . This highlights the different patterns in the microbiome that can be found when                             
assessing genetically heterogeneous sets of tumors; as  Dorea has been found to be increased in                             
tumor microbiomes by several different groups, whereas our work highlights some potential                       
genetic interactions that explain cases wherein  Dorea is not increased at the tumor site 3,5–8 . Thus,                             
incorporating genetic profiles in studies of the microbiome in CRC may be beneficial and                           
uncover  patterns  that  are  dependant  on  specific  tumor  mutations. 
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 Although it may be difficult to ascertain the biological mechanism behind the predicted                         
interactions among mutated genes and microbial taxa (shown in Fig. 2), it is possible to generate                               
hypotheses based on what is already known in the relevant literature. For example,  ANKRD36C                           
encodes a protein that may have a role in ion transport in epithelial cells 43 . Additionally, we find                                 
that LoF mutations in  APC correlate with changes in 25 different microbial taxa, including an                             
increase in the abundance of the genus Finegoldia . This genus has been identified in previous                             
studies of colon adenomas and also harbors species that act as opportunistic pathogens at sites                             
where the epithelium has been damaged 6,44,45 . In addition,  Capnocytophaga has been identified as                         
a potential biomarker for lung cancer 46 . Interestingly, changes in the abundance of                       
Christensenellaceae are predictive of mutations in both APC and  ZNF717 . A recent study in                           
twins has identified  Christensenellaceae as a taxon that is highly driven by host genetics 26 . We                             
find that mutations in  ZNF717 , a transcription factor commonly altered in gastric, hepatocellular,                         
and cervical cancers  47–49 , are associated with  Verrucomicrobiaceae and  Akkermansia , which are                       
both known to increase in conjunction with colitis 50 .  Alphaproteobacteria are significant                     
contributors to our ability to predict mutations in  CTBP2 , a repressor of transcription known to                             
interact with the ARF tumor suppressor 51 . Changes in this bacterial taxon’s abundance has also                           
been found to be associated with prostate cancer, however a mechanism of action was not                             
explored 52 . We also show that mutations in  KMT2C , a gene commonly co­mutated along with                           
KRAS,  could be predicted, in part, using the abundance of  Ruminococcus 53 . These bacteria have                           
been previously implicated in inflammatory bowel disorders and colorectal cancer by multiple                       
groups 8,54–56 .  
Similar results were also evident when aggregating the mutations into KEGG and PID                         
pathways (Fig. 3, Supplementary Figs. 4­5; see Methods)  30–33 . As an example, we find that the                               
abundance of microbes that predict KEGG pathways form two distinct clusters, and that the                           
genus  Escherichia has a higher scaled abundance in tumors with mutations in the KEGG                           
pathways in cluster 1 relative to those in cluster 2 (Supplementary Fig. 4). Cluster 1 contains                               
adherens junctions, which are partially responsible for maintaining the intestinal barrier and                       
interestingly, a disruption of the intestinal barrier in mice using cyclophosphamide was shown to                           
cause a loss of adherens junction function and a concomitant increase in bacterial translocation                           
into the intestinal tissue, including species of  Escherichia 57 . When examining the heatmap with                         
LoF mutation collapsed into PID pathways (Supplementary Fig. 5), we again find differences in                           
scaled microbial abundances between the tumors as a function of which pathways are mutated.                           
For instance, we find lower abundance of  Pseudomonas in tumors with LoF mutations in the                             
pathways ‘regulation of nuclear β­catenin signaling and target gene transcription’, ‘degradation                     
of β­catenin’, ‘presenilin action in Notch and Wnt signaling’, and ‘canonical Wnt signaling                         
pathways’. Recent studies have shown that  Pseudomonas strains that express the  LecB  gene can                           
lead to degradation of β­catenin, providing hypothetical support for the concept that this genus                           
may play a somewhat protective role in CRC by suppressing the Wnt signaling pathway 58 . The                             
mechanism that might explain this phenomenon is still unclear but may have to do with                             
alterations in appropriate cell surface adhesion molecules for the LecB protein or a change in the                               
content  of  the  cellular  microenvironment 58,59 .  
Many of the interactions identified here between bacterial taxa and mutations in PID                         
pathways have been demonstrated experimentally in the literature. For example, in human oral                         
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 cancer cells, it was shown that bacteria of interest were able to activate EGFR through the                               
generation of hydrogen peroxide 60 . In addition, the correlation between ErbB1 downstream                     
signaling and increase in the abundance of  Corynebacterium  has been demonstrated                     
mechanistically in a model of atopic dermatitis, whereby EGFR inhibition results in dysbiosis                         
(the appearance of  Corynebacterium species) and inflammation 61 . Specific depletion of                   
Corynebacterium ablates the inflammatory response 61 . Moreover, our finding that the abundance                     
of  Fusobacterium is depleted in tumors with LoF mutations in the PDGFR­beta pathway, which                           
may be explained by the dependence of several pathogenic strains of bacteria for functionally                           
intact PDGFR signaling for adherence to intestinal epithelium 62 . In addition, p75(NTR) signaling                       
has been shown to operate as a tumor suppressor by mediating apoptosis in response to hypoxic                               
conditions and reactive oxygen species 63–66 . Alterations in this pathway have also been shown to                           
be  useful  as  a  biomarker  for  esophageal  cancer 67,68 .  
Our study has several caveats. First, our study only shows correlations, and we cannot                           
directly assess causal effects. Thus, we do not know whether the microbiome is altered before or                               
after the appearance of specific mutations. Nevertheless, many of the predicted interactions                       
described above have been previously tested, albeit across a wide variety of experimental                         
systems and disease states, typically in isolation, for biological relevance and mechanism of                         
action. We expect that future studies will more comprehensively test the causality of interactions                           
by utilizing model organisms and cell culture techniques, where the effect of individual                         
mutations can be assessed. Additionally, we have only profiled the taxonomic composition of the                           
microbiome, and thus cannot detect interactions that are dependent on microbial genes or                         
functions. Similarly, using whole­exome sequencing does not allow us to include non­coding                       
mutations and larger tumor structural variants and chromosomal abnormalities. This can be                       
alleviated by the use of metagenomic shotgun sequencing to profile the microbiome, as well as                             
whole­genome sequencing to assess tumor mutations. Moreover, the study sample was relatively                       
small (n = 88 samples from 44 patients). Nevertheless, the sample size was sufficient to detect                               
significant patterns. Additional studies that use large tumor samples would be useful in                         
validating  our  results  and  identifying  further  associations.  
In summary, we present a strong association between tumor genetic profiles and the                         
proximal microbiome, and identify tumor genes and pathways that correlate with specific                       
microbial taxa. We also show that the microbiome can be used as a predictor of tumor mutated                                 
genes and pathways, and suggest potential mechanisms driving the interaction between the tumor                         
and its microbiota. Our proof­of­principle analysis can provide a starting point for the                         





88 tissue samples from 44 individuals were used, with one tumor and one normal sample                             
from each individual. These de­identified samples were obtained from the University of                       
Minnesota Biological Materials Procurement Network (Bionet), a facility that archives research                     
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 samples from patients who have provided written, informed consent. These samples were                       
previously utilized and are described in detail in a previous study 69 . To reiterate these points, all                               
research conformed to the Helsinki Declaration and was approved by the University of                         
Minnesota Institutional Review Board, protocol 1310E44403. Tissue pairs were resected                   
concurrently, rinsed with sterile water, flash frozen in liquid nitrogen, and characterized by staff                           
pathologists. The criteria for selection were limited to the availability of patient­matched normal                         
and  tumor  tissue  specimens.  Additional  patient  metadata  are  provided  in  the  indicated  work 69 . 
Microbiome  characterization 
The microbiome data used in the study was generated previously and is described                         
exhaustively in 69 . Briefly, microbial DNA was extracted from patient­matched normal and tumor                       
tissue samples using sonication for lysis and the AllPrep nucleic acid extraction kit (Qiagen,                           
Valencia, CA). The V5­V6 regions of the 16S rRNA gene were PCR amplified with the addition                               
of barcodes for multiplexing using the forward and reverse primer sets V5F and V6R from Cai,                               
et al. 70 . The barcoded amplicons were pooled and Illumina adapters were ligated to the reads. A                               
single lane on an Illumina MiSeq instrument was used (250 cycles, paired­end) to generate 16S                             
rRNA gene sequences. The sequencing resulted in approximately 10.7 million total reads passing                         
quality filtering in total, with a mean value of 121,470 quality reads per sample. The forward and                                 
reverse read pairs were merged using the USEARCH v7 program ‘fastq_mergepairs’, allowing                       
stagger, with no mismatches allowed 71 . OTUs were picked using the closed­reference picking                       
script in QIIME v1.7.0 using the Greengenes database (August 2013 release) 72–74 . The similarity                         
threshold was set at 97%, reverse­read matching was enabled, and reference­based chimera                       
calling  was  disabled.  
Exome  sequence  data  generation  
Genomic DNA samples were quantified using a fluorometric assay, the  Quant­iT                     
PicoGreen dsDNA Assay Kit (Life Technologies, Grand Island, NY) . Samples were considered                       
passing quality control (QC) if they contained greater than 300 nanograms (ng) of DNA and                             
display an A260:280 ratio above 1.7. Full workflow details for library preparation are outlined in                             
the Nextera Rapid Capture Enrichment Protocol Guide  (Illumina, Inc., San Diego, CA) . In brief,                           
libraries for Illumina next­generation sequencing were generated using Nextera library creation                     
reagents  (Illumina, Inc., San Diego, CA) .  A total of 50 ng of genomic DNA per sample were                                 
used as input for the library preparation. The DNA was tagmented (simultaneously tagged and                           
fragmented) using  Nextera transposome based fragmentation and transposition as part of the                       
Nextera Rapid Capture Enrichment kit (Illumina, Inc., San Diego, CA). This process added                         
Nextera adapters with complementarity to PCR primers containing sequences that allow addition                       
of Illumina flow cell adapters and dual­indexed barcodes. The tagmented DNA was amplified                         
using dual indexed barcoded primers.  The amplified and indexed samples were pooled (8                         
samples per pool) and quantified to ensure appropriate DNA concentrations and fragment sizes                         
using the  fluorometric PicoGreen assay and the Bioanalyzer High­Sensitivity DNA Chip                     
(Agilent Technologies, Santa Clara, CA).  Libraries were considered to pass QC as long as they                             
contained more than 500 ng of DNA and had an average peak size between 200 ­ 1000 base                                   
pairs. For hybridization and sequence capture, 500 nanograms of amplified library was                       
hybridized to biotinylated oligonucleotide probes complementary to regions of interest at 58° C                         
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 for 24 hours. Library­probe hybrids were captured using streptavidin­coated magnetic beads and                       
subjected to multiple washing steps to remove non­specifically bound material. The washed and                         
eluted library was subjected to a second hybridization and capture to further enrich target                           
sequences. The captured material was then amplified using 12 cycles of PCR. The captured,                           
amplified libraries underwent QC using a Bioanalyzer, and fluorometric PicoGreen assay.                     
Libraries were considered to pass QC as long as they contained a DNA concentration greater                             
than 10 nM and had an average size between 300 ­ 400 base pairs. Libraries were hybridized to a                                     
paired end flow cell at a concentration of 10 pM and individual fragments were clonally                             
amplified by bridge amplification on the Illumina cBot  (Illumina, Inc., San Diego, CA) .  Eleven                           
lanes on an Illumina HiSeq 2000 (Illumina, Inc., San Diego, CA) were required to generate the                               
desired sequences.  Once clustering was complete, the flow cell was loaded on the HiSeq 2000                             
and sequenced using Illumina’s SBS chemistry at 100 bp per read. Upon completion of read 1,                               
base pair index reads were performed to uniquely identify clustered libraries. Finally, the library                           
fragments were resynthesized in the reverse direction and sequenced from the opposite end of the                             
read 1 fragment, thus producing the paired end read 2. Full workflow details are outlined in                               
Illumina’s cBot User Guide and HiSeq 2000 User Guides. Base call (.bcl) files for each cycle of                                 
sequencing were generated by Illumina Real Time Analysis (RTA) software. The base call files                           
and run folders were then exported to servers maintained at the Minnesota Supercomputing                         
Institute. Primary analysis and de­multiplexing was performed using Illumina’s CASAVA                   
software 1.8.2. The end result of the CASAVA workflow was de­multiplexed FASTQ files that                           
were  utilized  in  subsequent  analysis  for  read  QC,  mapping,  and  mutation  calling. 
Exome  data  analysis 
The exome sequence data contained approximately 4.2 billion reads in total following                       
adapter removal and quality filtering, inclusive of forward and reverse reads, with a mean value                             
of 47.8 million high­quality reads per sample. The raw reads were assessed using FastQC                           
v0.11.2 and the Nextera adapters removed using cutadapt v1.8.1 75,76 . Simultaneously, cutadapt                     
was used to trim reads at bases with quality scores less than 20. Reads shorter than 40 bases were                                     
excluded. The trimmed and filtered read pairs were aligned and mapped to the human reference                             
genome (hg19) using bwa v0.7.10 resulting in a bam file for each patient sample 77 . These files                               
were further processed to sort the reads, add read groups, correct the mate­pair information, and                             
mark and remove PCR duplicates using picard tools v1.133 and samtools v0.1.18 78,79 .                       
Tumor­specific mutations were identified using FreeBayes v0.9.14­24­gc292036 80 . Following               
these steps, 94.0% of the remaining read pairs mapped to the reference genome, hg19.                           
Specifically, SNPs only were assessed and a minimum coverage at each identified mutation                         
position of more than 30X was required in both the patient normal and tumor samples. These                               
mutations were filtered to only include those that were within protein­coding regions and                         
compiled into a single vcf file. This vcf file was assessed using SNPeffect v4.1 K (2015­09­0) in                                 
order to predict the potential impact of each of the mutations 81 . Based on these results, the                               
mutations were grouped into three categories: (1) total mutations (2) non­synonymous mutations                       
and (3) loss of function (LoF) mutations. The total mutations group is self­explanatory. The                           
non­synonymous mutations included all the mutations in the total mutations group that were                         
non­silent. The LoF group only included those mutations that resulted in a premature stop codon,                             
a  loss  of  a  stop  codon,  or  a  frameshift  mutation. 
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 Joint  analysis  of  microbiome  and  exome  data  
Taxa that differentiated patients with or without LoF mutation were identified using                       
LEfSe 34 . All the taxa with a LDA score (log 10) > 2 were included in the calculation of the risk                                       
indices, built to predict the presence or absence of a LoF mutation based on the OTU table                                 
collapsed at genus level. To build the risk index, the relative abundances (arcsine square root                             
transformed) of the taxa associated with the LoF mutation (based on the LEfSe output) were                             
summed and the relative abundances of the taxa associated with no mutation (based on the                             
LEfSe output) were summed. The use of the unweighted sum in the risk index, rather than                               
relying on the regression coefficients from LDA, is a simple way to control the degree of                               
flexibility of the model when training on small sample sizes. More detail is described in a                               
previous publication 82 . Then the difference between these two sums was calculated, thereby                       
obtaining a risk index. This procedure was repeated 44 times to obtain a risk index for each                                 
patient. 
A leave­one­out procedure (also described above) was conducted to evaluate the taxa that                         
differentiated patients with or without LoF mutation in the held­out patient, based on the LEfSe                             
output of n­1 patients. In detail, the taxa that differentiated patients with or without LoF mutation                               
were identified using LEfSe in the n­1 dataset. The relative abundances of the taxa associated                             
with the LoF mutation (based on the LEfSe output of the n­1 dataset) were summed and the                                 
relative abundances of the taxa associated with no mutation (based on the LEfSe output of the                               
n­1 dataset) were summed and were used to build the risk index in the held­out patient. In detail,                                   
the difference between these two sums was calculated to obtain the risk index of the held­out                               
patient. This procedure was repeated 44 times, to produce a risk index in each of the held­out                                 
patients, based on the difference between the sum of the taxa associated with the absence of LoF                                 
mutation minus the sum of the taxa associated with the presence of the LoF mutation found in                                 
each of the n­1 datasets. The significance of the difference in risk indexes between the patients                               
with LoF mutation and patients with LoF mutation for each gene was assessed using a                             
Mann­Whitney U test and a permutation test, in which we permuted the labels for a given gene                                 
999 times, each time deriving new held­out predictions of the risk indexes for each subject for                               
that gene. Then the observed difference in means between the patients with LoF mutation and                             
patients with LoF mutation risk index predictions using the method on the actual LoF mutation                             
labels to the differences observed in the permutations to obtain an empirical P­value was                           
compared. The resulting P­values were corrected using the false discovery rate (FDR) correction                         
for  multiple  hypothesis  tests. 
Receiving Operating Characteristic (ROC) curves were plotted and the area under the                       
curve (AUC) values computed on a dataset containing 10 sets of predictions and corresponding                           
labels obtained from 10­fold cross­validation using ROCR package in R 83 .  A risk index threshold                           
was also obtained that best predicts the presence or absence of LoF mutation with a                             
leave­one­out cross­validation on the risk index. Each held­out sample was treated as a new                           
patient on whom the optimal risk index cutoff was tested and subsequently refined to separate                             
patients  who  had  a  LoF  mutation  and  patient  who  did  not  have  a  LoF.  
Correlation analysis was performed using SparCC on a reduced OTU table containing                       
significant taxa identified using the above prediction methods collapsed to the genus level 84 .                         
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 Pseudo p­values were calculated using 100 randomized sets. Networks of correlations were                       
visualized  using  Cytoscape  v3.1.0 85 . 
As this work is an extension of a previous study of the CRC­associated microbiome, each                             
of the patients in this project have associated clinical data 69 . We used a linear model to determine                                 
the extent to which any of these factors may correlate with mutation load. These included patient                               
sex, tumor stage, patient age, patient body mass index (BMI), and microsatellite instability (MSI)                           
status. None of these factors, alone or in combination, were found to significantly impact the                             
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 Figure  Legends 
Figure 1 |  Correlation between the microbial community at a tumor that differentiates                         
between tumor stage.  a , Low­stage (stages 1­2) and high­stage (stages 3­4) tumors can be                           
differentiated using a risk index classifier generated from microbial abundance data (y­axis). The                         
central black bar indicates the median, and the thin black bars represent the 25th and 75th                               
percentiles.  b , A receiver operating characteristic (ROC) curve was generated using a 10­fold                         
cross­validation (blue dotted lines). The average of the 10­fold cross­validation curves is                       
represented as a thick black line.  c , Differences in the mean abundances of a subset of the taxa                                   
predicted to interact differentially with high­stage and low­stage tumors. This subset represents                       
those  taxa  that  had  a  mean  difference  in  abundance  of  greater  than  0.1%,  proportionally. 
Figure 2 |  Commonly mutated genes show a predicted interaction with changes in the                           
abundances of several microbial taxa.  a , A heatmap of the scaled abundances values (cells) for                             
a subset of taxa chosen as they were identified as discriminatory in each leave­one­out iteration                             
(columns) that were found significantly associated with prevalent LoF mutations (rows). Scaled                       
abundances are from the patients with the indicated mutations.  b , LoF mutations in each of the                               
indicated genes can be predicted using a risk index as a classifier (y­axis). The central black bar                                 
indicates the median, and the thin black bars represent the 25th and 75th percentiles.  c , ROC                               
curves were generated for each of the indicated mutations using a 10­fold cross­validation (blue                           
dotted lines). The average of the 10­fold cross­validation curves is represented as a thick black                             
line.  d , Differences in the mean abundances of a subset of the taxa predicted to interact                               
differentially with tumors with a LoF mutation relative to those without the indicated mutation.                           
This subset represents those taxa that had a mean difference in abundance of greater than 0.1%,                               
proportionally. 
Figure 3 |  Pathways harboring prevalent LoF mutations correlate with changes in the                         
abundances of sets of microbial taxa.  a , A heatmap of the scaled abundances values (cells) for                               
a subset of taxa (columns) that are found significantly associated with KEGG pathways                         
harboring LoF mutations (rows). Scaled abundances are from the patients with mutations in the                           
indicated pathways.  b , LoF mutations in each of the indicated pathways can be predicted using a                               
risk index as a classifier (y­axis). The central black bar indicates the median, and the thin black                                 
bars represent the 2nd and 4th quartiles.  c , ROC curves were generated for each of the indicated                                 
pathways using a 10­fold cross­validation (blue dotted lines). The average of the 10­fold                         
cross­validation curves is represented as a thick black line.  d , Differences in the mean                           
abundances of a subset of the taxa predicted to interact differentially with tumors harboring                           
mutations in the indicated pathways relative to those without a mutation. This subset represents                           
those taxa that had a mean difference in abundance of greater than 0.1%, proportionally.  e ­  f ,                                 
Identically structured visualizations as in  a  ­  d , but for PID pathway data rather than the KEGG                                 
pathways. 
Figure 4 | Interaction networks among bacteria are defined by host tumor mutations.  a ,                           
SparCC analysis of the microbial abundances for taxa identified by LEfSe for APC with LoF                             
mutations (left) and without mutation (right) produce distinct patterns of correlations (edges)                       
between a common set of taxa (nodes). Direct correlations are indicated as red edges and inverse                               
correlations as blue edges (SparCC R >= 0.25, P <= 0.05 for displayed edges).  b , SparCC                               
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 analysis was run simultaneously for all taxa identified by LEfSe when predicting PID pathways.                           
There are interactions (dashed edges) between the taxa (grey nodes) associated with mutations                         
across sets of PID pathways (green nodes). The solid edges indicate SparCC R­values (red for                             
direct and blue for inverse correlations). The grey taxon nodes are scaled to the average                             
abundance of the taxa in the associated tumor set. Edge color indicates the direction of the                               
interaction,  red  for  negative  and  blue  for  positive.   
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